Trials / Sponsors / Laura Huppert, MD, BA
Laura Huppert, MD, BA
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer HER2 Low Breast Carcinoma, Triple Negative Breast Cancer, Hormone-receptor-positive Breast Cancer | Phase 2 | 2026-03-01 |
| Active Not Recruiting | Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectabl Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer | Phase 2 | 2019-07-08 |
| Completed | Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease Breast Cancer, Chest Wall Disease | Phase 2 | 2017-09-02 |